Results 21 to 30 of about 11,080 (216)

Hyperviscosity-Related Ischemic Stroke in an Adolescent With Unrepaired Tetralogy of Fallot: A Case Report From a Resource-Limited Setting. [PDF]

Clin Case Rep
ABSTRACT Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease. Chronic hypoxemia in uncorrected TOF causes compensatory erythrocytosis and hyperviscosity, predisposing to cerebrovascular complications. Stroke in this context is rare but clinically significant, especially in resource‐limited settings where access to imaging and
Wolie AA, Mengistie CT, Mengistie BT, Mulatu ED, Teferi RN, Andeta BT, Minwagaw GT.   +6 more
europepmc   +2 more sources

Autosomal Dominant Erythrocytosis Caused by Non-Renal Erythropoietin (EPO) Due to EPO c.-136 G>A Germline Mutation. [PDF]

Am J Hematol
A novel erythropoietin (EPO) promoter mutation (c.‐136 G>A) causes autosomal dominant erythrocytosis via non‐renal expression of EPO. ABSTRACT We previously reported a five‐generation kindred with autosomal dominant erythrocytosis associated with a novel germline promoter variant in the erythropoietin (EPO) gene (EPO c.‐136 G>A).
Lanikova L, Hrckulak D, Zimolova V, Lorenzo FR, Song J, Vecerkova K, Babosova O, Berkova L, Korinek V, Elliott S, Prchal JT.   +10 more
europepmc   +2 more sources

Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial Erythrocytosis. [PDF]

Drug Test Anal
A basic EPO IEF profile was identified in patients with familial erythropoiesis linked to mutations in noncoding parts of EPO gene. Comparison of blood and urine EPO profiles from these patients differed from adult wild‐type EPO (WT) and from Eprex‐administered patients. Patients' EPO do not differ from WT EPO after analysis using SDS‐PAGE/SAR‐PAGE. It
Martin L, Idriss S, Maaziz N, Huerre S, Mekacher LR, Lahmek K, Girodon F, Gardie B, Ericsson M, Marchand A.   +9 more
europepmc   +2 more sources

Identification of Variants Associated With Rare Hematological Disorder Erythrocytosis Using Targeted Next-Generation Sequencing Analysis

Frontiers in Genetics, 2021
An erythrocytosis is present when the red blood cell mass is increased, demonstrated as elevated hemoglobin and hematocrit in the laboratory evaluation.
Aleša Kristan, Tadej Pajič, Tadej Pajič, Tadej Pajič, Aleš Maver, Tadeja Režen, Tanja Kunej, Rok Količ, Andrej Vuga, Martina Fink, Martina Fink, Špela Žula, Helena Podgornik, Helena Podgornik, Saša Anžej Doma, Saša Anžej Doma, Irena Preložnik Zupan, Irena Preložnik Zupan, Damjana Rozman, Nataša Debeljak   +19 more
doaj   +1 more source

Relationships Between Chemoreflex Responses, Sleep Quality, and Hematocrit in Andean Men and Women. [PDF]

, 2020
Andean highlanders are challenged by chronic hypoxia and many exhibit elevated hematocrit (Hct) and blunted ventilation compared to other high-altitude populations.
Anza-Ramirez, Cecilia, Corante, Noemi, DeYoung, Pamela N, Djokic, Matea A, Gaio, Eduardo, Gilbertson, Dillon, Heinrich, Erica C, Macarlupu, Jose L, Malhotra, Atul, Orr, Jeremy E, Powell, Frank L, Simonson, Tatum S, Villafuerte, Francisco C, Vizcardo-Galindo, Gustavo   +13 more
core   +1 more source

Posttransplant erythrocytosis [PDF]

Kidney International, 2003
Posttransplant erythrocytosis (PTE) is defined as a persistently elevated hematocrit to a level greater than 51% after renal transplantation. It occurs in 10% to 15% of graft recipients and usually develops 8 to 24 months after engraftment. Spontaneous remission of established PTE is observed in one fourth of the patients within 2 years from onset ...
Vlahakos, Demetrios V., Marathias, Katerina P., Agroyannis, Basil, Madias, Nicolaos E.   +3 more
openaire   +2 more sources

The genomic analysis brings a new piece to the molecular jigsaw of idiopathic erythrocytosis

Experimental Hematology & Oncology, 2022
Erythrocytosis is a clinical condition characterized by increased red cell mass, hemoglobin, and hematocrit values. A significant fraction of patients is described as having idiopathic erythrocytosis.
Antonella Zagaria, Francesco Tarantini, Paola Orsini, Luisa Anelli, Cosimo Cumbo, Nicoletta Coccaro, Giuseppina Tota, Crescenzio Francesco Minervini, Elisa Parciante, Maria Rosa Conserva, Immacolata Redavid, Alessandra Ricco, Immacolata Attolico, Giorgina Specchia, Pellegrino Musto, Francesco Albano   +15 more
doaj   +1 more source

Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study

BMJ Open Respiratory Research, 2021
Background Multidrug-resistant tuberculosis (MDR-TB) drugs have never been associated with erythrocytosis. In Eritrea, however, several cases of incident erythrocytosis had been observed in the MDR-TB hospital.
Henok Woldu, Sirak Tesfamariam, Mulugeta Russom, Amon Solomon Ghebrenegus, Ephrem Fisseha, Gebremeskel Belai   +5 more
doaj   +1 more source

Unusual Neurologic Manifestations of a Patient with Cyanotic Congenital Heart Disease after Phlebotomy [PDF]

, 2015
Secondary erythrocytosis in cyanotic congenital heart disease (CCHD) is a compensatory response to chronic hypoxia which should be managed with caution.
Assadi, Majid, Mehdizadeh, Somayeh, Nemati, Reza, Pourbehi, Gholam Reza, Pourbehi, Mohamad Reza, Salimipour, Hooman   +5 more
core   +10 more sources

Thrombotic and hemorrhagic complications in idiopathic erythrocytosis [PDF]

, 2017
We report clinical features of a large cohort of patients with IE compared to a cohort of patients with PV, focusing on the thrombotic and hemorrhagic ...
Bertozzi, Irene, Biagetti, Giacomo, Cosi, Elisabetta, Nichele, Ilaria, Randi, Maria Luigia, Ruggeri, Marco   +5 more
core   +1 more source